visual ( v ) , somatosensory ( s ) and brainstem auditory ( ba ) evoked potentials ( eps ) were determined in 22 epileptic patients , mostly with partial seizures , who received add-on treatment with vigabatrin ( 1-3 g/day , stratified according to body weight ) and placebo , each given for 7 weeks according to a double-blind , randomized cross-over design .
C0014544
epileptic
C0048044
vigabatrin